Biopharmaceutics in Drug Development:Mechanistic Insights into Absorption,Bioavailability, and Dosage FormPerformance

Abstract

Biopharmaceutics is a fundamental discipline in drug development that examines the interplay between drug physicochemical properties, formulation design, and biological systems influencing drug absorption and bioavailability. This study highlights mechanistic insights into key processes such as dissolution, permeability, and first-pass metabolism that determine dosage form performance and therapeutic outcomes. The role of the biopharmaceutics classification system as a predictive framework for formulation optimization and bioequivalence
assessment is discussed. Physiological factors affecting drug absorption, including gastrointestinal conditions, food effects, and interindividual variability, are critically examined. The study addresses advanced drug delivery approaches, including controlled-release systems and nanocarrier-based formulations, developed to overcome
biopharmaceutic challenges associated with poorly soluble and poorly permeable drugs. In addition, the significance of predictive tools, such as in vitro–in vivo correlation and physiologically based pharmacokinetic
modeling, in supporting rational formulation development and regulatory decision-making is emphasized. Overall, this review underscores the importance of biopharmaceutics as an integrative science that enhances drug development efficiency and ensures consistent therapeutic performance of pharmaceutical products.